Insider Transactions Reported by 26 Insiders of Vor Biopharma Inc.

Symbol
VOR on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Vor Biopharma Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $108,428,028 -$33,715,155 -24% 18 Dec 2025
Reprogrammed Interchange LLC 10%+ Owner $35,094,788 -$15,360,223 -30% 17 Oct 2025
5AM Ventures VI, L.P. 10%+ Owner $3,215,274 16 Nov 2021
Qing Che Zuraw Chief Development Officer $993,304 05 Dec 2025
ROBERT ANG PRESIDENT AND CEO, Director $510,338 06 May 2025
Nathan D. Jorgensen Chief Financial Officer $331,455 06 May 2024
Eyal C. Attar Chief Medical Officer $179,808 13 Feb 2025
Tirtha Chakraborty Chief Sci Off & Head Tech Ops $121,752 06 May 2025
Amy Quinlan Vice President of Finance $43,268 06 Nov 2024
Han Wook Choi Chief Financial Officer $33,844 01 May 2025
Sandesh Mahatme Cfo $0 05 Dec 2025
Kush Parmar Director, 10%+ Owner 14 Jun 2022
Daniella Beckman Director 22 May 2025
Christopher Slapak Chief Medical Officer 01 Feb 2022
Joshua Resnick Director 22 May 2025
Jean-Paul Kress CEO and Chairman, Director 05 Dec 2025
Sarah Burgess Reed Director 08 Sep 2025
Andrew David Levin Director 18 Dec 2025
Michel Detheux Director 16 Jul 2025
Wouter Joustra Director 18 Dec 2025
Fouad Namouni Director 22 May 2025
Erez Kalir Director 22 May 2025
Alexander Cumbo Director 16 Jul 2025
David Charles Lubner Director 22 May 2025
Matthew R. Patterson Director 22 May 2025
Sven Ante Lundberg Director 22 May 2025

Recent Insider Transactions by Companies or Individuals for Vor Biopharma Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.